Originally published as JHC exPRESS on May 27, 2005. doi:10.1369/jhc.5B6708.2005
Volume 53 (9): 1177-1180, 2005 Copyright ©The Histochemical Society, Inc.
Establishment of Stable GH3 Cell Line Expressing Enhanced Yellow Fluorescein ProteinGrowth Hormone Fusion Protein
Department of Neurosurgery, Teikyo University Ichihara Hospital, Ichihara City, Chiba, Japan (AMa,TN); Basic Medical Science and Molecular Medicine (AMi), Teaching and Research Support Center (JI), and Department of Pathology (ST,RYO), Tokai University School of Medicine, Boseidai, Isehara City, Kanagawa, Japan; and Division of Endocrinology, Department of Internal Medicine, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan (HO,KT) Correspondence to: Akira Matsuno, MD, PhD, Department of Neurosurgery, Teikyo University Ichihara Hospital, 3426-3 Anesaki, Ichihara City, Chiba 299-0111, Japan. E-mail: akirakun{at}med.teikyo-u.ac.jp
To investigate, in real time, the transport and secretion of pituitary hormone, we have developed an experimental pituitary cell line, GH3 cell, which has secretory granules of growth hormone (GH) linked to enhanced yellow fluorescein protein (EYFP). This stable GH3 cell secretes secretory granules of GH linked to EYFP on stimulation by Ca2+ influx or Ca2 release from storage. This GH3 cell will be useful for the real-time visualization of the intracellular transport and secretion of GH. (J Histochem Cytochem 53:11771180, 2005)
Key Words: EYFP GH GH3 cell
WE HAVE INVESTIGATED THE MODULATIONS of the intracellular dynamics of growth hormone (GH), rab3B, soluble N-ethylmaleimidesensitive factor attachment protein receptor proteins such as synaptosomal-associated protein of 25 kDa and syntaxin in rat pituitary cells, caused by growth hormone-releasing hormone and somatostatin (Matsuno et al. 2003a The rat GH cDNA clone pRGH-1 and the EYFP-expression construct pEYFP-N1 were obtained from the American Type Culture Collection (Manassas, VA) and Clontech Laboratories, Inc. (Palo Alto, CA), respectively. The GH-EYFP fusion construct pCMV-Sig-EYFP-GH-1 was derived from pEYFP-N1 and contained a sequence encoding the rat GH signal peptide (1 to 26 in the rat GH amino acid sequence) and the EYFP-coding segment, followed by another rat GH coding sequence (27 to 217 in the rat GH amino acid sequence). GH3 cells were maintained at 37C in a 5% CO2 in DMEM/Ham's F-12 medium supplemented with 2.5% heat-inactivated FBS, 10% horse serum, 100 U/ml of penicillin, and 100 µg/ml of streptomycin. Transfection of GH3 cells was performed using lipofectamine 2000 (Invitrogen Corporation; Carlsbad, CA). Briefly, GH3 cells at 70% confluency on poly-L-lysincoated dishes were transfected with plasmid DNA in low-serum Opti-MEM (Invitrogen Corp.; Carlsbad, CA) using lipofectamine 2000 for 45 hr. The transfected cells were washed and incubated in DMEM/Ham's F-12 medium (Invitrogen) for 3648 hr before microscopic observation, harvest for immunoblot analyses, or selection of stable transformants in DMEM/Ham's F-12 medium supplemented with final concentration of 250 µg/ml of Geneticin (Invitrogen). The GH3 cell transfected with pCMV-sig-EYFP-GH-1 had secretory granules that emitted yellow color in the cytoplasm. To prepare whole-cell extracts for immunoblot analyses, transfected cells were heated at 100C in Laemmli sample buffer for 10 min, sonicated, and cleared by centrifugation. The extracts were fractionated on a 12.5% and blotted onto a nitrocellulose membrane. For the detection of GH-EYFP fusion proteins, anti-rat GH polyclonal antibody (National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD) and anti-rabbit IgG-HRP Fab (Amersham International plc; Buckinghamshire, UK) were used as primary and secondary antibodies, respectively, and signals were detected with ECL-Plus chemiluminescence reagents. The Western blotting showed a 22-kDa band of native GH protein and a 75-kDa band of GH-EYFP fusion protein (Figure 1).
Cells were incubated with culture medium of high K 60 mEq/L concentration and were observed under confocal laser scanning microscopy (CLSM), which showed that granules of GH were secreted (Figure 2). Cells were stimulated with thyrotropin releasing hormone of 107 M concentration and observed under CLSM, which showed that granules of GH were secreted (Figure 3). Cells were treated with thyrotropin releasing hormone 107 M and nitrendipine 1 µM and were observed under CLSM, which showed that only a few granules of GH were secreted (Figure 4). Control experiment with no treatment showed no secretion of secretory granules (Figure 5).
Green fluorescent protein (GFP) has been used widely in cell biology for the real-time visualization of cellular processes (Tsien 1998
Received for publication April 3, 2005; accepted April 14, 2005
Magoulas C, McGuinness L, Balthasar N, Carmignac DF, Sesay AK, Mathers KE, Christian H, et al. (2000) A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice. Endocrinology 141:46814689 Matsuno A, Itoh J, Takekoshi S, Itoh Y, Ohsugi Y, Katayama H, Nagashima T, et al. (2003a) Dynamics of subcellular organelles, growth hormone, rab3B, SNAP-25, and syntaxin in rat pituitary cells caused by growth hormone releasing hormone and somatostatin. Microsc Res Tech 62:232239[Medline] Matsuno A, Itoh J, Takekoshi S, Nagashima T, Osamura RY (2003b) Functional and morphological analyses of rab proteins and the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) system in the secretion of pituitary hormones. Acta Histochem Cytochem 36:501506[CrossRef] Tsien RY (1998) The green fluorescent protein. Annu Rev Biochem 67:509544[CrossRef][Medline]
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||